Analyst Activity – Scotiabank Reiterates Underperform on Concordia International Corp (TSE:CXR)

ME Staff
-
0

Analyst Ratings For Concordia International Corp (TSE:CXR)

Today, Scotiabank reiterated its Underperform rating on Concordia International Corp (TSE:CXR).

There are 5 sell ratings, 1 hold rating on the stock.

The current consensus rating on Concordia International Corp (TSE:CXR) is Sell (Score: 1.17) with a consensus target price of C$26.13 per share, a potential .

Some recent analyst ratings include

  • 3/16/2017-Scotiabank Reiterated Rating of Underperform.
  • 2/9/2017-TD Securities was Downgraded by analysts at TD Securities from a “Hold ” rating to a ” Reduce” rating.
  • 12/8/2016-Royal Bank of Canada was Downgraded by analysts at Royal Bank of Canada from a “Sector Perform ” rating to a ” Underperform” rating.
  • 11/7/2016-Bloom Burton was Downgraded by analysts at Bloom Burton from a “Hold ” rating to a ” Sell” rating.
  • 8/15/2016-CIBC was Downgraded by analysts at CIBC from a “Sector Perform ” rating to a ” Underperform” rating.


    About Concordia International Corp (TSE:CXR)
    Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

    Recent Trading Activity for Concordia International Corp (TSE:CXR)
    Shares of Concordia International Corp closed the previous trading session at 2.63 down -0.02 -0.75% with 275,192 shares trading hands.